text:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ Form 10-Q __________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-23993 __________________________________ Broadcom Corporation (Exact Name of Registrant as Specified in Its Charter) __________________________________
5300 California Avenue Irvine, California 92617-3038 (Address of Principal Executive Offices) (Zip Code) (949) 926-5000 (Registrant's telephone number, including area code) __________________________________ Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x As of September 30, 2012 the registrant had 512 million shares of Class A common stock, $0.0001 par value, and 52 million shares of Class B common stock, $0.0001 par value, outstanding. BROADCOM CORPORATION QUARTERLY REPORT ON FORM 10-Q FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2012 TABLE OF CONTENTS
Broadcom® and the pulse logo are among the trademarks of Broadcom Corporation and/or its affiliates in the United States, certain other countries and/or the EU. Any other trademarks or trade names mentioned are the property of their respective owners. © 2012 Broadcom Corporation. All rights reserved. 1 PART I. FINANCIAL INFORMATION
See accompanying notes. 2 BROADCOM CORPORATION UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
The following table presents details of total stock-based compensation expense included in each functional line item in the unaudited condensed consolidated statements of income above:
See accompanying notes. 3 BROADCOM CORPORATION UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
See accompanying notes. 4 BROADCOM CORPORATION UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
See accompanying notes. 5 BROADCOM CORPORATION NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS September 30, 2012
Our Company Broadcom Corporation (including our subsidiaries, referred to collectively in this Report as "Broadcom," "we," "our" and "us") is a global leader and innovator in semiconductor solutions for wired and wireless communications. Broadcom® products seamlessly deliver voice, video, data and multimedia connectivity in the home, office and mobile environments. We provide the industry's broadest portfolio of state-of-the-art system-on-a-chip, or SoC, and embedded software solutions. Basis of Presentation The interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP, for interim financial information and with the instructions to Securities and Exchange Commission, or SEC, Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended December 31, 2011, included in our Annual Report on Form 10-K filed with the SEC on February 1, 2012. In February 2012 we completed our acquisition of NetLogic Microsystems, Inc., or NetLogic and in April 2012 we completed our acquisition of BroadLight, Inc., or BroadLight. The unaudited condensed consolidated financial statements include the results of operations of NetLogic and BroadLight commencing as of the acquisition dates and are included in our Infrastructure & Networking and Broadband Communications reportable segments, respectively. See Note 3 for a further discussion. The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly our consolidated financial position at September 30, 2012 and December 31, 2011, and our consolidated results of operations for the three and nine months ended September 30, 2012 and 2011 and cash flows for the nine months ended September 30, 2012 and 2011. The results of operations for the three and nine months ended September 30, 2012 are not necessarily indicative of the results to be expected for future quarters or the full year. Use of Estimates The preparation of financial statements in accordance with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the dates of the financial statements and the reported amounts of total net revenue and expenses in the reporting periods. We regularly evaluate estimates and assumptions related to revenue recognition, rebates, allowances for doubtful accounts, sales returns and allowances, warranty obligations, inventory valuation, stock-based compensation expense, goodwill and purchased intangible asset valuations, strategic investments, deferred income tax asset valuation allowances, uncertain tax positions, tax contingencies, self-insurance, restructuring costs or reversals, litigation and other loss contingencies. These estimates and assumptions are based on current facts, historical experience and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not readily apparent from other sources. The actual results we experience may differ materially and adversely from our estimates. To the extent there are material differences between the estimates and actual results, our future results of operations will be affected. Revenue Recognition We derive revenue principally from sales of integrated circuit products, royalties and license fees for our intellectual property and software and related services. The timing of revenue recognition and the amount of revenue actually recognized for each arrangement depends upon a variety of factors, including the specific terms of each arrangement and the nature of our deliverables and obligations. Determination of the appropriate amount of revenue recognized involves judgments and estimates that we believe are reasonable, but actual results may differ from our estimates. We recognize product revenue when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price to the customer is fixed or determinable, and (iv) collection of the resulting receivable is reasonably assured. These criteria are 6 usually met at the time of product shipment. However, we do not recognize revenue when any future performance obligations remain. We record reductions of revenue for estimated product returns and pricing adjustments, such as competitive pricing programs and rebates, in the same period that the related revenue is recorded. The amount of these reductions is based on historical sales returns, analysis of credit memo data, specific criteria included in rebate agreements, and other factors known at the time. We accrue 100% of potential rebates at the time of sale and do not apply a breakage factor. We reverse the accrual for unclaimed rebate amounts as specific rebate programs contractually end and when we believe unclaimed rebates are no longer subject to payment and will not be paid. See Note 2 for a summary of our rebate activity. Multiple Element Arrangements Excluding Software We occasionally enter into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect our results of operations. When we enter into an arrangement that includes multiple elements, the allocation of value to each element is derived based on management's best estimate of selling price when vendor specific evidence or third party evidence is unavailable. Distributor Revenue A portion of our product sales is made through distributors under agreements allowing for pricing credits and/or rights of return. These pricing credits and/or right of return provisions prevent us from being able to reasonably estimate the final price of the inventory to be sold and the amount of inventory that could be returned pursuant to these agreements. As a result, the fixed and determinable revenue recognition criterion has not been met at the time we deliver products to our distributors. Accordingly, product revenue from sales made through these distributors is not recognized until the distributors ship the product to their customers. Software, Royalties and Cancellation Fee Revenue Revenue from software licenses is recognized when all of the software revenue recognition criteria are met and, if applicable, when vendor specific objective evidence, or VSOE, exists to allocate the total license fee to each element of multiple-element software arrangements, including post-contract customer support. Post-contract support is recognized ratably over the support period. When a contract contains multiple elements wherein the only undelivered element is post-contract customer support and VSOE of the fair value of post-contract customer support does not exist, revenue from the entire arrangement is recognized ratably over the support period. Software royalty revenue is recognized in arrears on a quarterly basis, based upon reports received from licensees during the period, unless collectability is not reasonably assured, in which case revenue is recognized when payment is received from the licensee. Revenue from cancellation fees is recognized when cash is received from the customer. Licensing Revenue We license or otherwise provide rights to use portions of our intellectual property, which includes certain patent rights essential to and/or utilized in the manufacture and sale of certain wireless products. Licensees typically pay a license fee in one or more installments and ongoing royalties based on their sales of products incorporating or using our licensed intellectual property. License fees are recognized over the estimated period of benefit to the licensee or the term specified. We recognize licensing revenue on the sale of patents when all of the following criteria are met: (i) persuasive evidence of an arrangement exist, (ii) delivery has occurred, (iii) the price to be paid by the purchaser is fixed or determinable and (iv) collection of the resulting accounts receivable is reasonably assured. These criteria are usually met at the time of patent transfer. We recognize royalty revenues based on royalties reported by licensees and when other revenue recognition criteria are met, which is generally a quarter in arrears from the period earned. Income from the Qualcomm Agreement On April 26, 2009 we entered into a four-year Settlement and Patent License and Non-Assert Agreement, or the Qualcomm Agreement, with Qualcomm Incorporated, or Qualcomm. The Qualcomm Agreement is a multiple element arrangement which includes: (i) an exchange of intellectual property rights, including in certain circumstances, by a series of covenants not to assert claims of patent infringement under future patents issued within one to four years of the execution date 7 of the agreement, (ii) the assignment of certain existing patents by Broadcom to Qualcomm with Broadcom retaining a royalty-free license under these patents, and (iii) the settlement of all outstanding litigation and claims between us and Qualcomm. The proceeds of the Qualcomm Agreement were allocated amongst the principal elements of the transaction. A gain of $65 million from the settlement of litigation was immediately recognized as a reduction in settlement costs that approximates the value of awards determined by the United States District Court for the Central District of California. The remaining consideration was predominantly associated with the transfer of current and future intellectual property rights and is being recognized within net revenue over the performance period of four years as a single unit of accounting. However this income will be limited to the lesser of the cumulative straight-line amortization over the four year performance period or the cumulative cash proceeds received. Deferred Revenue and Income We defer revenue and income when advance payments are received from customers before performance obligations have been completed and/or services have been performed. Deferred revenue does not include amounts from products delivered to distributors that the distributors have not yet sold through to their end customers. Fair Value of Financial Instruments Our financial instruments consist principally of cash and cash equivalents, short- and long-term marketable securities, accounts receivable, accounts payable and long-term debt. The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows: Level 1: Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date. Level 2:Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date. Level 3:Inputs include management's best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument's valuation. The fair value of the majority of our cash equivalents and marketable securities was determined based on "Level 1" inputs. The fair value of certain marketable securities and our long-term debt were determined based on "Level 2" inputs. The valuation techniques used to measure the fair value of our "Level 2" instruments were valued based on quoted market prices or model driven valuations using significant inputs derived from or corroborated by observable market data. We do not have any marketable securities in the "Level 3" category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. Cash, Cash Equivalents and Marketable Securities We consider all highly liquid investments that are readily convertible into cash and have a maturity of three months or less at the time of purchase to be cash equivalents. The cost of these investments approximates their fair value. We maintain an investment portfolio of various security holdings, types and maturities. We define marketable securities as income yielding securities that can be readily converted into cash. Marketable securities' short-term and long-term classifications are based on remaining maturities at each reporting period. Examples of marketable securities include U.S. Treasury and agency obligations, commercial paper, asset-back securities and corporate bonds. We place our cash investments in instruments that meet various parameters, including credit quality standards as specified in our investment policy. We do not use derivative financial instruments. We account for our investments in debt instruments as available-for-sale. Management determines the appropriate classification of such securities at the time of purchase and re-evaluates such classification as of each balance sheet date. Cash equivalents and marketable securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income (loss), a component of shareholders' equity, net of tax. We assess whether our investments with unrealized loss positions are other than temporarily impaired. Unrealized gains and losses and declines in 8 value judged to be other than temporary are determined based on the specific identification method and are reported in other income, net in the consolidated statements of income. Goodwill and Other Long-Lived Assets Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the acquired net tangible and intangible assets. Other long-lived assets primarily represent purchased intangible assets including developed technology, customer relationships and in-process research and development, or IPR&D. We currently amortize our intangible assets with definitive lives over periods ranging from one to fourteen years using a method that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise used or, if that pattern cannot be reliably determined, using a straight-line amortization method. We capitalize IPR&D projects acquired as part of a business combination. On completion of each project, IPR&D assets are reclassified to developed technology and amortized over their estimated useful lives. Impairment of Goodwill and Other Long-Lived Assets We evaluate goodwill on an annual basis in the fourth quarter or more frequently if we believe indicators of impairment exist. We first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we conclude that it is more likely than not that the fair value of a reporting units is less than its carrying amount, we conduct a two-step goodwill impairment test. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their carrying values. We determine the fair values of our reporting units using the income valuation approach, as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, we perform the second step of the goodwill impairment test. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit's goodwill with the carrying value of that goodwill. The amount, by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. During development, IPR&D is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. We first assess qualitative factors to determine whether it is more likely than not that the fair value of IPR&D is less than its carrying amount, and if so, we conduct a quantitative impairment test. The impairment test consists of a comparison of the fair value to its carrying amount. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Once an IPR&D project is complete, it becomes a definite lived intangible asset and is evaluated for impairment in accordance with our policy for long-lived assets. We test long-lived assets and purchased intangible assets (other than goodwill and IPR&D in development) for impairment if we believe indicators of impairment exist. We determine whether the carrying value of an asset or asset group is recoverable, based on comparisons to undiscounted expected future cash flows that the assets are expected to generate. If an asset is not recoverable, we record an impairment loss equal to the amount by which the carrying value of the asset exceeds its fair value. We primarily use the income valuation approach to determine the fair value of our long lived assets and purchased intangible assets. Guarantees and Indemnifications In some agreements to which we are a party, we have agreed to indemnify the other party for certain matters, including, but not limited to product liability. We include intellectual property indemnification provisions in our standard terms and conditions of sale for our products and have also included such provisions in certain agreements with third parties. We have and will continue to evaluate and provide reasonable assistance for these other parties. This may include certain levels of financial support to minimize the impact of the litigation in which the other parties are involved. To date, there have been no known events or circumstances that have resulted in any material costs related to these indemnification provisions and no liabilities therefor have been recorded in the accompanying consolidated financial statements. However, the maximum potential amount of the future payments we could be required to make under these indemnification obligations could be significant. We have obligations to indemnify certain of our present and former directors, officers and employees to the maximum extent not prohibited by law. Under these obligations, Broadcom is required (subject to certain exceptions) to indemnify each such director, officer and employee against expenses, including attorneys' fees, judgments, fines and settlements, paid by such individual. The potential amount of the future payments we could be required to make under these indemnification obligations could be significant. We maintain directors' and officers' insurance policies that may generally limit our exposure and enable us to recover a portion of the amounts paid with respect to such obligations. 9 Stock-Based Compensation Broadcom has in effect stock incentive plans under which incentive stock options have been granted to employees and restricted stock units and non-qualified stock options have been granted to employees and non-employee members of the Board of Directors. We also have an employee stock purchase plan for all eligible employees. We are required to estimate the fair value of share-based awards on the date of grant. The value of the award is principally recognized as an expense ratably over the requisite service periods. The fair value of our restricted stock units is based on the closing market price of our Class A common stock on the date of grant less our expected dividend yield. We have estimated the fair value of stock options and stock purchase rights as of the date of grant or assumption using the Black-Scholes option pricing model, which was developed for use in estimating the value of traded options that have no vesting restrictions and that are freely transferable. The Black-Scholes model considers, among other factors, the expected life of the award, the expected volatility of our stock price and the expected dividend yield. We evaluate the assumptions used to value stock options and stock purchase rights on a quarterly basis. The fair values generated by the Black-Scholes model may not be indicative of the actual fair values of our equity awards, as it does not consider other factors important to those awards to employees, such as continued employment, periodic vesting requirements and limited transferability. Litigation and Settlement Costs Legal costs are expensed as incurred. We are involved in disputes, litigation and other legal actions in the ordinary course of business. We continually evaluate uncertainties associated with litigation and record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated. In the event of settlement discussions, this generally occurs when an agreement in principle has been reached by both parties that includes substantive terms, conditions and amounts. If a settlement has more than one element, we account for the agreement as a multiple element arrangement and allocate the consideration to the identifiable elements based on relative fair value. Past multiple element settlement agreements have included the licensing of intellectual property for future use and payments related to alleged prior infringement. We use a relief-from-royalty method to value patented technology in settlement agreements related to alleged patent infringement, based on market royalties for similar fundamental technologies. The relief-from-royalty method estimates the cost savings that accrue to the owner of an intangible asset that would otherwise be payable as royalties or license fees on revenues earned through the use of the asset. The royalty rate used is based on an analysis of empirical, market-derived royalty rates for guideline intangible assets. Revenue is projected over the expected remaining useful life of the patented technology, or the license period if shorter. The market-derived royalty rate is then applied to estimate the royalty stream related to past revenue over the applicable alleged infringement period as well as projected revenue. We then allocate the consideration transferred to the identifiable elements based on relative fair value of the past and future royalties. The portion that is attributed to payments related to alleged prior infringement is recorded as a charge to our unaudited condensed consolidated statements of income. The remaining portion is attributed to the licensing of intellectual property for future use and is amortized to cost of revenue using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used or, if that pattern cannot be reliably determined, using a straight-line amortization method. Recent Accounting Pronouncements In June 2011 the Financial Accounting Standards Board, or FASB, issued guidance regarding the presentation of comprehensive income. The new standard requires the presentation of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The updated guidance is effective on a retrospective basis for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2011. We adopted the provisions of this guidance effective January 1, 2012, as reflected in the unaudited condensed consolidated statements of comprehensive income herein. In July 2012 the FASB issued new accounting guidance intended to simplify indefinite-lived intangible asset impairment testing. Entities will now be allowed to perform a qualitative assessment on indefinite-lived intangible asset impairment to determine whether a quantitative assessment is necessary. This guidance is effective for indefinite-lived intangible asset impairment tests performed in interim and annual periods for fiscal years beginning after September 15, 2012. Early adoption is permitted. We adopted the provisions of this guidance effective September 30, 2012. 10
Net Revenue The following table presents details of our product revenue:
Income from the Qualcomm Agreement is expected to be recognized as follows:
Inventory The following table presents details of our inventory:
Property and Equipment The following table presents details of our property and equipment:
11 Goodwill The following table summarizes the activity related to the carrying value of our goodwill:
Purchased Intangible Assets The following table presents details of our purchased intangible assets:
In the nine months ended September 30, 2012 we reclassified $1 million of IPR&D costs related to previous acquisitions to developed technology and such costs will now be amortized to cost of product revenue. For a detailed discussion of our various impairments of purchased intangible assets, see Note 10. The following table presents details of the amortization of purchased intangible assets included in the cost of product revenue and other operating expense categories:
12 The following table presents details of the amortization of existing purchased intangible assets (including IPR&D), which is currently estimated to be expensed in the remainder of 2012 and thereafter:
Accrued Liabilities The following table presents details of our accrued liabilities included in current liabilities:
Other Long-Term Liabilities The following table presents details of our other long-term liabilities:
13 Accrued Rebate Activity The following table summarizes the activity related to accrued rebates:
We recorded rebates to certain customers of $216 million and $184 million in the three months ended September 30, 2012 and 2011, respectively. Warranty Reserve Activity The following table summarizes activity related to the warranty reserve:
We recorded charges to costs and expenses of $2 million in each of the three months ended September 30, 2012 and 2011. Restructuring Activity The following table summarizes activity related to our current and long-term restructuring liabilities during the nine months ended September 30, 2012:
Charitable Contribution In June 2011 we contributed $25 million to the Broadcom Foundation to support science, technology, engineering and mathematics programs, as well as a broad range of community services. This payment was recorded as an operating expense in our unaudited condensed consolidated statements of income in the nine months ended September 30, 2011. 14 Computation of Net Income Per Share The following table presents the computation of net income per share:
Net income per share (diluted) does not include the effect of anti-dilutive common share equivalents resulting from outstanding equity awards. There were 26 million and 23 million anti-dilutive common share equivalents in the three months ended September 30, 2012 and 2011, respectively, and 23 million and 21 million anti-dilutive common share equivalents in the nine months ended September 30, 2012 and 2011, respectively. Supplemental Cash Flow Information In the nine months ended September 30, 2012 we accrued $1 million related to stock option exercises that had not settled by September 30, 2012. In the nine months ended September 30, 2012, we paid $41 million for capital equipment that was accrued as of December 31, 2011 and had billings of $25 million for capital equipment that were accrued but not yet paid as of September 30, 2012.
On February 17, 2012 we completed our acquisition of NetLogic, a publicly traded company that was a provider of high performance intelligent semiconductor solutions for next generation networks. Our primary reasons for acquiring NetLogic were to enhance our ability to deliver a complete, end-to-end network infrastructure solution for customers and to reduce both time-to-market and development costs. The addition of NetLogic also extends Broadcom's infrastructure portfolio with key technologies, including multi-core embedded processor and knowledge-based processor solutions, both critical enablers of the next generation infrastructure build-out. In April 2012 we completed our acquisition of BroadLight, a provider of networking and fiber access Passive Optical Network, or PON, processors. Our primary reason for acquiring BroadLight was to extend Broadcom's broadband access product line, enabling Broadcom to offer a complete, end-to-end PON solution for customers — from the optical line terminal at the central office to the optical network unit at the home. BroadLight also extends Broadcom's broadband access roadmap to support customer requirements for rolling out next-generation fiber networks worldwide. In addition, these acquisitions allowed us to enter into or expand our market share in the relevant wired and wireless communications market segments, reduce the time required to develop new technologies and products and bring them to market, incorporate enhanced functionality into and complement our existing product offerings, augment our engineering workforce, and enhance our technological capabilities. 15 The following table presents details of the purchase consideration related to each acquisition:
The purchase price of the NetLogic acquisition was paid in cash, except for certain equity awards with a fair value of $349 million that were assumed. Approximately $137 million of the equity consideration was recorded as goodwill and $212 million will be recognized as stock-based compensation expense primarily over the next two to three years. A portion of the cash consideration in the BroadLight acquisition is currently held in escrow pursuant to the terms of the acquisition agreement and is reflected in goodwill as we believe the likelihood of the escrow fund being utilized by us is remote. In connection with these acquisitions, our results of operations in the three months ended September 30, 2012 included: (i) stock-based compensation of $25 million, (ii) the amortization of purchased intangibles of $63 million, and (iii) the amortization of acquired inventory valuation step-up of $5 million. In connection with these acquisitions, our results of operations in the nine months ended September 30, 2012 included: (i) stock-based compensation of $77 million, of which $17 million related to the accelerated vesting of equity awards upon the termination of certain employees with change in control agreements, (ii) the amortization of purchased intangibles of $156 million, and (iii) the amortization of acquired inventory valuation step-up of $68 million. We also incurred certain severance and other benefit costs of $3 million in the nine months ended September 30, 2012 that are classified as restructuring costs in our unaudited condensed consolidated statement of income. Lastly, we incurred $6 million in transaction costs related to legal, accounting and other related fees, of which $1 million was recorded in the nine months ended September 30, 2012 in selling, general and administrative expense and the remaining was previously expensed in 2011. We have estimated the fair value of the acquired assets and liabilities of BroadLight. We allocated the respective purchase prices to tangible assets, liabilities and identifiable intangible assets acquired based on their estimated respective fair values. The excess of the purchase price over the aggregate fair values was recorded as goodwill, of which $23 million is deductible for tax purposes. The principal factor that resulted in recognition of goodwill was that the purchase price for each acquisition was based on cash flow projections assuming the integration of any acquired technology and products with our products, which is of considerably greater value than utilizing each acquired company's technology or product on a standalone basis. The fair value assigned to identifiable intangible assets acquired was based on estimates and assumptions made by management at the time of the acquisitions. 16 Based upon those calculations, the purchase prices for the acquisitions were allocated as follows:
Purchased Intangible Assets Developed technology represents patented technology and completed technology. Patented technology is the fundamental technology that survives multiple product iterations, while completed technology is specific to certain products acquired. Both of these technologies have passed technological feasibility. We generally use a relief-from-royalty method or market transactions to value patented technology, based on market royalties or prices for similar fundamental technologies. The relief-from-royalty method estimates the cost savings that accrue to the owner of an intangible asset that would otherwise be payable as royalties or license fees on revenues earned through the use of the asset. The royalty rate used is based on an analysis of empirical, market-derived royalty rates for guideline intangible assets. Typically, revenue is projected over the expected remaining useful life of the patented technology. The market-derived royalty rate is then applied to estimate the royalty savings. To value completed technology, we generally use a multi-period excess earnings approach which calculates the value based on the risk-adjusted present value of the cash flows specific to the products, allowing for a reasonable return. The fair value of the IPR&D from our acquisitions was determined using the income approach. Under the income approach, the expected future cash flows from each project under development are estimated and discounted to their net present values at an appropriate risk-adjusted rate of return. Significant factors considered in the calculation of the rate of return are the weighted average cost of capital, the return on assets, as well as the risks inherent in the development process, including the 17 likelihood of achieving technological success and market acceptance. Each project was analyzed to determine the unique technological innovations, the existence and reliance on patented technology, the existence of any alternative future use or current technological feasibility, and the complexity, cost and time to complete the remaining development. Future cash flows for each project were estimated based on forecasted revenue and costs, taking into account the expected product life cycles, market penetration and growth rates. We believe the amount recorded as IPR&D, as well as developed technology, represented the fair value and approximate the amount a market participant would pay for these projects as of the acquisition date. The following table summarizes the significant assumptions underlying the valuation of IPR&D at the date of acquisition:
There was no IPR&D related to our other acquisitions. The assumptions consist primarily of expected completion dates for the IPR&D projects, estimated costs to complete the projects, and revenue and expense projections for the products once they have entered the market. Research and development costs to bring the products of the acquired companies to technological feasibility are not expected to have a material impact on our results of operations or financial condition. Actual results to date have been consistent, in all material respects, with our assumptions at the time of the acquisitions. Customer relationships represent the fair value of future projected revenue that will be derived from the sale of products to existing customers of the acquired companies. Contingent Earn-out Consideration In connection with our NetLogic acquisition, we assumed a liability of $53 million related to contingent consideration in connection with one of NetLogic's prior acquisitions and subsequently paid this amount in the nine months ended September 30, 2012. Additional cash consideration of up to $57 million may be paid to the former shareholders of this prior acquisition upon satisfaction of certain future performance goals. Additional contingent earn-out consideration of up to $10 million in cash may be paid to the former holders of BroadLight capital stock and other rights upon satisfaction of certain future performance goals. As of September 30, 2012 we do not have any liabilities recorded in connection with any remaining contingent earn-out consideration, as we believe that the achievement of the future performance goals is unlikely. Supplemental Pro Forma Data (Unaudited) The unaudited pro forma statement of income data below gives effect to our 2012 and 2011 acquisitions as if they had occurred at the beginning of the year prior to their respective acquisition dates. The following data includes the effects of amortization of purchased intangible assets and acquired inventory valuation step-up, stock-based compensation expense, foregone interest as a result of cash paid to acquire the companies, and other one-time transactions costs directly associated with the acquisitions such as legal, accounting and banking fees. This pro forma data is presented for informational purposes only and does not purport to be indicative of the results of future operations or of the results that would have occurred had the acquisitions taken place in the periods noted above.
Instruments Measured at Fair Value on a Recurring Basis. The following tables present our cash and marketable securities' costs, gross unrealized gains, gross unrealized losses and fair value by major security type recorded as cash and cash equivalents or short-term or long-term marketable securities:
19 There were no transfers between Level 1, Level 2 or Level 3 securities in the nine months ended September 30, 2012. All of our long-term marketable securities had maturities of between one and three years in duration at September 30, 2012. Our cash, cash equivalents and marketable securities at September 30, 2012 consisted of $1.88 billion held domestically, with the remaining balance of $1.31 billion held by foreign subsidiaries. At September 30, 2012 we had 39 investments with a fair value of $382 million that were in an unrealized loss position for less than 12 months. Our gross unrealized losses of less than one million dollars for these investments at September 30, 2012 were due to changes in interest rates. We have determined that the gross unrealized losses on these investments at September 30, 2012 are temporary in nature. We evaluate securities for other-than-temporary impairment on a quarterly basis. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment in order to allow for an anticipated recovery in fair value. Instruments Not Recorded at Fair Value on a Recurring Basis. We measure the fair value of our long-term debt carried at amortized cost quarterly for disclosure purposes. The estimated fair value of long-term debt is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. Based on the market prices, the fair value of our long-term debt was $1.76 billion and $1.22 billion as of September 30, 2012 and December 31, 2011 respectively. The recorded values of all our accounts receivable and accounts payable approximate their current fair values because of their nature and respective relatively short maturity dates or durations. Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis. We measure the fair value of our cost method investments when they are deemed to be other-than-temporarily impaired, assets acquired and liabilities assumed in a business acquisition, and goodwill and other long lived assets when they are held for sale or determined to be impaired. See Notes 3 and 10 for discussion on fair value measurements of certain assets and liabilities recorded at fair value on a non-recurring basis.
We recorded tax benefits of $9 million and $62 million for the three and nine months ended September 30, 2012, respectively, and tax provisions of $6 million and $7 million for the three and nine months ended September 30, 2011, respectively. Our effective tax rates were (4.3)% and (15.3)% for the three and nine months ended September 30, 2012, respectively, and 2.2% and 1.0% for the three and nine months ended September 30, 2011, respectively. The difference between our effective tax rates and the 35% federal statutory rate resulted primarily from foreign earnings taxed at rates lower than the federal statutory rate in the three and nine months ended September 30, 2012 and 2011, tax benefits resulting primarily from the expiration of statutes of limitations for the assessment of taxes in various foreign jurisdictions of $7 million for the nine months ended September 30, 2012, and $6 million for the nine months ended September 30, 2011, tax benefits resulting from the reduction of certain foreign deferred tax liabilities of $12 million for the three and nine months ended September 30, 2012, and tax benefits resulting from reductions in our U.S. valuation allowance on certain deferred tax assets due to recording net deferred tax liabilities for identifiable intangible assets under purchasing accounting of $47 million and $4 million for our acquisitions of NetLogic and BroadLight, respectively, for the nine months ended September 30, 2012. During the three months ended March 31, 2012, we accessed $1.5 billion of cash from our foreign subsidiaries to facilitate the acquisition of NetLogic. This $1.5 billion was treated as includable in our U.S. taxable income for 2012. Nevertheless, this did not result in a tax liability for us because it was offset by our net operating loss and tax credit carryforwards. The $3.61 billion cash purchase price to acquire NetLogic greatly exceeded the purchase price of any prior cash acquisition we have made. The acquisition of NetLogic was unusual and nonrecurring. Our other cash acquisitions have been for significantly lower purchase prices, and we have never previously determined it prudent or necessary to access our prior years' foreign earnings to facilitate an acquisition. We do not currently expect any future need to access our prior years' foreign earnings, and therefore, aside from the $1.5 billion used to facilitate the NetLogic acquisition, we intend to continue to permanently reinvest our foreign earnings. We utilize the asset and liability method of accounting for income taxes. We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. As a result of our recent cumulative tax losses in the U.S. and certain foreign jurisdictions, and the full utilization of our loss carryback opportunities, we have concluded that a full valuation allowance should be recorded in such jurisdictions. In certain other foreign jurisdictions where we do not have cumulative losses, we had net deferred tax liabilities of $35 million and $62 million at September 30, 2012 and December 31, 20 2011, respectively. We file federal, state and foreign income tax returns in jurisdictions with varying statutes of limitations. The 2007 through 2011 tax years generally remain subject to examination by federal and most state tax authorities. In foreign jurisdictions, the 2004 through 2011 tax years generally remain subject to examination by tax authorities. Our income tax returns for the 2007, 2008 and 2009 tax years are currently under examination by the Internal Revenue Service. On June 30, 2011 we concluded the Internal Revenue Service (IRS) examination of our income tax returns for 2004 through 2006, executed a closing agreement covering the 2001 through 2006 tax years, and agreed to certain adjustments for the 2001 through 2006 tax years, primarily related to intercompany transfer pricing transactions. Those audit adjustments were offset by federal net operating losses and credits, and did not result in any income tax expense or cash tax liability for us. As a result of the IRS examination, taking into account effects on post-audit periods, we reduced our federal and state net operating losses by approximately $620 million and $430 million, respectively, and we reduced amounts relating to federal and state uncertain tax benefits by approximately $180 million and $100 million, respectively, as of June 30, 2011. This reduction in federal and state net operating loss carryforwards was fully offset with a reduction in our valuation allowance for deferred tax assets, and had no impact on our operating results or financial position. In December, 2010 the Tax Relief, Unemployment Insurance Reauthorization and Job Creation Act of 2010 was enacted. A provision in this legislation provided for the extension of the research and development tax credit for qualifying expenditures paid or incurred from January 1, 2010 through the expiration date of December 31, 2011. As a result of this legislation, we generated federal research and development tax credits of $118 million for the year ended December 31, 2011. These tax credits, if unutilized, will carry forward to future periods. No tax benefit was recorded for these carryovers since we have a full valuation allowance on our U.S. net deferred tax assets. We operate under tax holidays in Singapore, which are effective through March 2014. The tax holidays are conditional upon our meeting certain employment and investment thresholds. We have begun discussions with the Singapore Economic Development Board with respect to tax incentives for periods after March 31, 2014.
The following table presents details of our long-term debt liabilities:
In August 2012 we issued senior unsecured notes in an aggregate principal amount of $500 million which mature in August 2022 and bear interest at a fixed rate of 2.500% per annum, or the 2022 Notes. Interest is payable in cash semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2013. The 2022 Notes were issued at an effective yield of 2.585% and an original issue discount at 99.255%. In connection with the 2022 Notes, we entered into a registration rights agreement pursuant to which we agreed to use our reasonable commercial efforts to file with the SEC an exchange offer registration statement to issue registered notes with substantially identical terms as the 2022 Notes in exchange for any outstanding 2022 Notes, or, under certain circumstances, a shelf registration statement to register the 2022 Notes. We agreed to use our commercially reasonable efforts to consummate the exchange offer or cause the shelf registration statement to be declared effective by the SEC, in each case on or prior to 365 days after the closing of the 2022 Notes offering. If we are unable to complete our registration statement, we will be subject to interest penalties. 21 We may redeem the 2022 Notes at any time, subject to a specified make-whole premium as defined in the indenture governing the 2022 Notes. In the event of a change of control triggering event, each holder of 2022 Notes will have the right to require us to purchase for cash all or a portion of their 2022 Notes at a redemption price of 101% of the aggregate principal amount of such 2022 Notes plus accrued and unpaid interest. Default can be triggered by any missed interest or principal payment, breach of covenant, or in certain events of bankruptcy, insolvency or reorganization. The Notes contain a number of restrictive covenants, including, but not limited to, restrictions on our ability to grant liens on assets; enter into sale and lease-back transactions; or merge, consolidate or sell assets. Failure to comply with these covenants, or any other event of default, could result in acceleration of the principal amount and accrued but unpaid interest on the Notes. These 2022 Notes are recorded as long-term debt, net of original issue discount. The discount and debt issuance costs associated with the issuance of the 2022 Notes are amortized to interest expense over the term. The effective rates for the fixed-rate debt include the interest on the notes and the accretion of the original issue discount. Relative to our overall indebtedness, the notes rank in right of payment (i) equal with all of our other existing and future senior unsecured indebtedness (ii) senior to all of our existing and future subordinated indebtedness, and (iii) effectively subordinated to all of our subsidiaries' existing and future indebtedness and other obligations (including secured and unsecured obligations) and subordinated to our existing and future secured indebtedness and other obligations, to the extent of the assets securing such indebtedness and other obligations. We also have a credit facility with certain institutional lenders that provides for unsecured revolving facility loans, swing line loans and letters of credit in an aggregate amount of up to $500 million with a maturity date of November 19, 2016, at which time all outstanding revolving facility loans (if any) and accrued and unpaid interest must be repaid. No amounts were outstanding on our credit facility at September 30, 2012 and December 31, 2011. The long-term debt and credit facility contain customary representations, warranties and covenants.
Quarterly Dividend In January 2012 our Board of Directors adopted an amendment to the existing dividend policy pursuant to which we increased the quarterly cash dividend by 11.1% to $0.10 per share ($0.40 per share on an annual basis) payable to holders of our common stock. In the three and nine months ended September 30, 2012 and 2011 we paid $56 million, $167 million, $48 million and $145 million, respectively, in dividends to holders of our Class A and Class B common stock. These dividends were paid from U.S. domestic sources other than our retained earnings and are accounted for as reductions of shareholders' equity. Share Repurchase Program In February 2010, we announced that our Board of Directors had authorized an evergreen share repurchase program intended to offset dilution of incremental grants of stock awards associated with our stock incentive plans. The maximum number of shares of our Class A common stock that may be repurchased in any one year under this program (including under an accelerated share repurchase agreement or other arrangement) is equal to the total number of shares issued pursuant to our equity awards in the previous year and the current year. This program does not have an expiration date and may be suspended at any time at the discretion of the Board of Directors. It may also be complemented with an additional share repurchase program in the future. Under the evergreen program we repurchased approximately 28,000 shares of our Class A common stock at a weighted average price of $35.18 in the three and nine months ended September 30, 2012. Repurchases under our share repurchase programs were and are intended to be made in open market or privately negotiated transactions in compliance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended, or the Exchange Act. 22
Combined Incentive Plan Activity Activity under all stock option incentive plans is set forth below:
Restricted stock unit activity is set forth below:
The per share fair values of rights granted in connection with the employee stock purchase plan and stock options assumed from acquisitions in the nine months ended September 30, 2012 have been estimated with the following weighted average assumptions:
23 Stock-Based Compensation Expense The following table presents details of total stock-based compensation expense that is included in each functional line item in the unaudited condensed consolidated statements of income:
The following table presents details of unearned stock-based compensation currently estimated to be expensed in the remainder of 2012 through 2016 related to unvested share-based payment awards:
The weighted-average period over which the unearned stock-based compensation is expected to be recognized is 1.40 years.
Litigation We and certain of our subsidiaries are currently parties to various legal proceedings, including those noted in this section. Unless otherwise noted below, during the period presented we have not: recorded any accrual for loss contingencies associated with such legal proceedings; determined that an unfavorable outcome is probable or reasonably possible; or determined that the amount or range of any possible loss is reasonably estimable. We are engaged in numerous other legal actions not described below arising in the ordinary course of our business and, while there can be no assurance, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position. From time to time we may conclude it is in the best interests of our shareholders, employees, and customers to settle one or more litigation matters, and any such settlement could include substantial payments; however, other than as noted below, we have not reached this conclusion with respect to any particular matter at this time. There are a variety of factors that influence our decisions to settle and the amount we may choose to pay, including the strength of our case, developments in the litigation, the behavior of other interested parties, the demand on management time and the possible distraction of our employees associated with the case and/or the possibility that we may be subject to an injunction or other equitable remedy. It is difficult to predict whether a settlement is possible, the amount of an appropriate settlement or when is the opportune time to settle a matter in light of the numerous factors that go into the settlement decision. Intellectual Property Proceedings In September 2009 we filed a complaint in the United States District Court for the Central District of California against Emulex Corporation, or Emulex, alleging infringement of ten patents generally relating to networking technologies. In subsequent filings, we added two additional patents and withdrew six patents, bringing the total to six asserted patents: U.S. Patents Nos. 7,058,150; 7,471,691; 7,450,500; 6,424,194; 7,486,124, and 7,724,057 (referred to as the Asserted Patents). In its answers, Emulex denied liability and asserted counterclaims seeking a declaratory judgment that the Asserted Patents are invalid and not infringed. A trial occurred in September and October 2011, and the Court heard post-trial motions in December 2011. The Court found that the Asserted Patents are not invalid. The Court further found Emulex infringed the '150 and '691 patents. In March 2012, the Court granted Broadcom's motion for an injunction on the '150 and '691 patents and in April 2012, the Court entered an injunction against Emulex. Emulex filed an appeal of the Court's rulings on the '150 and '691 patents to the Federal Circuit. On the remaining Asserted Patents, the jury found the '500 patent was not infringed and failed to reach a 24 verdict on infringement for the '194, '124, and '057 patents. The Court has scheduled a new trial regarding the '194, '124, and '057 patents for April 2013. On July 3, 2012, Broadcom and Emulex entered into a partial settlement and license agreement for the Asserted Patents. Under the terms of the agreement, the parties dismissed their respective claims on the '691 and '500 patents, Emulex received a license and release related to the Asserted Patents for certain products for certain fields of use and Emulex was required to make a payment of certain amounts to Broadcom. The litigation proceedings for the '150, '194, '124, and '057 patents will continue relating to Emulex's unlicensed activity. In November 2009 we filed a complaint in the United States District Court for the Eastern District of Texas against the Commonwealth Scientific and Industrial Research Organisation, or CSIRO, seeking a declaratory judgment that a certain U.S. patent number is invalid, unenforceable and not infringed. CSIRO answered the complaint and counterclaimed for infringement against Broadcom wireless LAN products and sought damages, attorney's fees, and an injunction. Following a court ordered mediation session in March 2012, Broadcom and CSIRO entered into a settlement agreement resolving the litigation and the Court dismissed the parties' claims with prejudice. The terms of the settlement agreement included a full release from liability for all asserted claims, the grant of a perpetual license under the asserted patent and all related patents to Broadcom, and the payment of certain amounts by Broadcom. In August 2010, we filed a motion to intervene (i.e., to be added as a party) in U.S. Ethernet Innovations, LLC v. Acer, Inc., Case No. 10-cv-03724-JW (N.D. Cal.). In this case, U.S. Ethernet Innovations, LLC, or USEI, filed a patent infringement complaint alleging that numerous companies, including certain of our customers, infringe patents relating generally to Ethernet technology. USEI seeks monetary damages, attorney's fees, and an injunction. Defendants have filed answers denying the allegations in USEI's complaint and asserting counterclaims for declaratory judgment that USEI's patents are invalid, unenforceable, and not infringed. We contend that we have a license related to USEI's patents and are seeking to assert this license as a defense. In December 2010, the Court granted our motion to intervene. No trial date has been set. We and our subsidiaries are also involved in other intellectual property proceedings, claims and litigation. We will disclose the nature of any such matter if we believe it to be material. Particularly in the early stages of such proceedings, an assessment of materiality may be complicated by limited information, including, without limitation, limited information about the patents-in-suit and Broadcom products against which the patents are being asserted. Accordingly, our assessment of materiality may change in the future based upon availability of discovery and further developments in the proceedings at issue. Some of these intellectual property proceedings may involve, for example, "non-practicing entities" asserting claims addressing certain of our products. The resolution of intellectual property litigation can include, among other things, payment of damages, royalties, or other amounts, which could adversely, impact our product gross margins in future periods, or could prevent us from manufacturing or selling some of our products or limit or restrict the type of work that employees may perform for us. In addition, from time to time we are approached by holders of intellectual property, including non-practicing entities, to engage in discussions about our obtaining licenses to their intellectual property. We will disclose the nature of any such discussion if we determine that (i) it is probable an intellectual property holder will assert a claim of infringement, (ii) there is a reasonable possibility the outcome (assuming assertion) will be unfavorable, and (iii) the resulting liability would be material to our financial condition. Other Proceedings In November 2009 Emulex filed a complaint in the Central District of California against us alleging violation of the antitrust laws, defamation, and unfair competition. The complaint seeks injunctive relief and monetary damages, including treble damages and attorneys' fees. In January 2010, Emulex filed an amended complaint in which Emulex removed, among other things, the claim of unfair competition. In February 2010, we filed motions to dismiss the case and a motion to strike. In June 2010, the District Court granted in part and denied in part our motion to dismiss and denied our motion to strike. In April 2012, the Court granted a joint stipulation to dismiss Emulex's antitrust, defamation, and unfair competition case against us without prejudice. Under the July 3, 2012 agreement referenced above, Emulex released these claims against Broadcom. In April 2008 we delivered a Notice of Arbitration and Arbitration Claim to our former independent registered public accounting firm Ernst & Young LLP, or E&Y, and certain related parties. The arbitration relates to the issues that led to the restatement of our financial statements for the periods from 1998 through March 31, 2006 as disclosed in an amended Annual Report on Form 10-K/A for the year ended December 31, 2005 and an amended Quarterly Report on Form 10-Q/A for the three months ended March 31, 2006, each filed with the SEC January 23, 2007. In May 2008 E&Y delivered a Notice of Defense and Counterclaim. The arbitration hearing has been scheduled for January 2013. 25 In September 2011, two lawsuits were filed by stockholders of NetLogic purporting to assert claims arising from our entry into a definitive merger agreement with NetLogic under which a subsidiary of Broadcom, I&N Acquisition Corp., was to be merged with and into NetLogic. On November 11, 2011, all parties to these actions, captioned New Jersey Carpenters' Pension Fund v. Broyles et al., (Cal. Super. Ct. County of Santa Clara, Case No. 1-11-CV-209381) (referred to as the California Action), and Danielo v. NetLogic Microsystems, et al., (Del. Ct. of Chancery, Case No. 6881-VCG) (referred to as the Delaware Action), executed a Memorandum of Understanding, or MOU, respecting a proposed settlement of the claims in each of those actions. The California court entered a final order approving the settlement, and the Delaware court has dismissed the case with prejudice. The terms of the settlement required NetLogic to make certain supplemental disclosures regarding the merger in a Form 8-K filed with the SEC by NetLogic on November 14, 2011, and the payment by NetLogic of attorneys fees' and costs to counsel representing the plaintiffs in the amount of $795,000. In February 2012 we were notified by the SEC's Division of Enforcement - Los Angeles Regional office that it is conducting a formal investigation of our accounting practices related to litigation reserves. The SEC has requested documents and information for the time period commencing June 1, 2010 to the present. We believe that the SEC's investigation was prompted by allegations of a former employee relating to our processes and decisions regarding litigation reserves in the first quarter of 2011 in connection with asserted and unasserted intellectual property claims. Following our receipt of these allegations in April 2011, we, with oversight from the Audit Committee of the Board of Directors, conducted an internal review of these allegations with the assistance of independent outside counsel and did not identify any improprieties. This investigation was completed during the three months ended June 30, 2011. In addition, based on the internal review, the results of which were discussed with the our independent registered public accounting firm, we determined that no adjustments to our fiscal 2010 and March 31, 2011 consolidated financial statements were necessary relating to the subject matter of the review. We are cooperating with the SEC's investigation. In July 2012, a former employee filed a lawsuit against us alleging wrongful termination in violation of the Dodd-Frank Wall Street Reform and Consumer Protection Act and fundamental public policy under state law. The former employee alleges that he was terminated in June 2011 because he raised concerns that Broadcom did not appropriately accrue for and report certain loss contingencies in the three months ended March 31, 2011. We believe the lawsuit is without merit. General We and our subsidiaries are also involved in other legal proceedings, claims and litigation arising in the ordinary course of business. We will disclose the nature of any such matter if we believe it to be material. The pending proceedings described above involve complex questions of fact and law and may require the expenditure of significant funds and the diversion of other resources to prosecute and defend. The results of legal proceedings are inherently uncertain, and material adverse outcomes are possible. From time to time we may enter into confidential discussions regarding the potential settlement of pending intellectual property or other litigation or other proceedings; however, there can be no assurance that any such discussions will occur or will result in a settlement. In the course of such settlement discussions, if we conclude that a settlement loss is probable and the settlement amount is estimable we may record settlement costs, notwithstanding not having reached a final settlement agreement. The settlement of any pending litigation or other proceedings could require us to incur substantial settlement payments and costs. Furthermore, the settlement of any intellectual property proceeding may require us to grant a license to certain of our intellectual property rights to the other party under a cross-license agreement. If any of those events were to occur, our business, financial condition and results of operations could be materially and adversely affected. See Note 1 for an additional discussion of our accounting policy under "Litigation and Settlement Costs". Settlement Costs (Gains) and Other Related Items In three months ended September 30, 2012 we received a payment of $58 million related to a partial settlement and license agreement. We accounted for this transaction as a multiple element arrangement and immediately recognized a $2 million gain on settlement of litigation and allocated the remaining $56 million to the licensing of intellectual property. The licensing portion will be recorded as net revenue over the ten year term of the license. In the nine months ended September 30, 2012 we recorded settlement costs of $88 million related to the settlement of patent infringement claims. In the three months ended September 30, 2011 we recorded net settlement costs of $27 million related to the settlement of patent infringement claims, which net amount was comprised of $30 million of settlement costs, offset by $3 million of settlement gains. In the nine months ended September 30, 2011 we recorded net settlement gains of $23 million which was comprised of $54 million of settlement gains primarily related to the settlement of our shareholder derivative action, offset by settlement costs of $31 million related to the settlement of patent infringement claims. Upon the occurrence of certain events, 26 we may be required to record additional settlement costs of up to $20 million related to a patent infringement case that settled in 2011. Commitments and Other Contractual Obligations The following table presents details of our commitments and other contractual obligations, which are currently estimated to be paid in the remainder of 2012 and thereafter:
Inventory and related purchase obligations represent purchase commitments for silicon wafers and assembly and test services. We depend upon third party subcontractors to manufacture our silicon wafers and provide assembly and test services. Due to lengthy subcontractor lead times, we must order these materials and services from subcontractors well in advance. We expect to receive and pay for these materials and services within the ensuing six months. Our subcontractor relationships typically allow for the cancellation of outstanding purchase orders, but require payment of all expenses incurred through the date of cancellation. Other obligations represent purchase commitments for lab test equipment, computer hardware, information systems infrastructure, mask and prototyping costs, intellectual property licensing arrangements and other commitments made in the ordinary course of business. For purposes of the table above, obligations for the purchase of goods or services are defined as agreements that are enforceable and legally binding and that specify all significant terms, including: fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Our purchase orders are based on current manufacturing needs and are typically fulfilled by our vendors within a relatively short time horizon. We have additional purchase orders (not included in the table above) that represent authorizations to purchase rather than binding agreements. We do not have significant agreements for the purchase of inventories or other goods specifying minimum quantities or set prices that exceed our expected requirements.
In September 2012 we recorded impairment charges for developed technology of $48 million, primarily related to our 2011 acquisition of Provigent, Inc. included in our Infrastructure & Networking reportable segment. The primary factor contributing to this impairment charge was the reduction of forecasted cash flows related to certain legacy microwave technology products. In June 2012 we recorded impairment charges for developed technology of $6 million, primarily related to our 2010 acquisition of Beceem Communications, Inc., or Beceem, included in our Mobile & Wireless reportable segment. The primary factor contributing to this impairment charge was the continued reduction in the forecasted cash flows derived from the acquired WiMAX products as wireless service providers have accelerated their adoption of Long Term Evolution, LTE, products. Additionally, we recorded an impairment charge of $3 million related to certain computer software and equipment in June 2012. In March 2012 we recorded impairment charges for developed technology of $28 million, primarily related to our acquisitions of Dune Networks, Inc. and Percello Ltd. included in our Infrastructure & Networking and Broadband Communications reportable segments, respectively. The primary factor contributing to these impairment charges was the reduction in the revenue outlook for certain products and the resulting decrease to the estimated cash flows identified with the impaired assets. In September 2011 we recorded a purchased intangible impairment charge of $9 million primarily related to our acquisition of Teknovus, Inc. in 2010. The primary factor contributing to this impairment charge was a reduction in the forecasted cash flows related to this networking business. In June 2011 we recorded a purchased intangible impairment charge of $74 million related to our acquisition of Beceem. The primary factor contributing to this impairment charge was a reduction 27 in the forecasted cash flows derived from the acquired WiMAX products as discussed above. In March 2011 we recorded an impairment charge of $9 million primarily related to a technology license that was acquired in 2008. The primary factor contributing to this impairment charge was the continued reduction in our revenue outlook for our Blu-ray business, and the related decrease to the estimated cash flows identified with the impaired assets. In determining the amount of the impairment charges we calculated fair values as of the impairment date for acquired developed technology. The fair value was determined using the multiple period excess earnings method, described in Note 3. The fair values were determined using significant unobservable inputs categorized as Level 3 inputs. The key unobservable inputs utilized in the model include discount rates ranging from 15% to 25%, a market participant tax rate of 15%, and a probability adjusted level of future cash flows based on current product and market data.
Business Enterprise Segments Broadcom has three reportable segments consistent with our target markets. Our three reportable segments are: Broadband Communications (Home), Mobile & Wireless (Hand) and Infrastructure & Networking (Infrastructure). Our Chief Executive Officer, who is our chief operating decision maker, or CODM, reviews financial information at the reportable segment level. Our net revenue is generated principally from sales of integrated circuit products, the income we receive from our agreement with Qualcomm and licensing revenue. While we derive some revenue from other sources, that revenue is not material as it represents approximately 1% of our total net revenue. Such revenue is classified under product revenue for reporting purposes. We group our net revenue consistent with our three target markets which comprise our reportable segments, as discussed above. With respect to the sales of integrated circuit products, we have approximately 600 products that are grouped into approximately 60 product lines. We have concluded that these products constitute a group of similar products within each reportable segment in each of the following respects:
We also report an "All Other" category that primarily includes licensing revenue and income from the Qualcomm Agreement since it is principally the result of corporate efforts. "All Other" also includes operating expenses that we do not allocate to our other operating segments as these expenses are not included in the segment operating performance measures evaluated by our CODM. Operating costs and expenses that are not allocated include stock-based compensation, amortization of purchased intangible assets, amortization of acquired inventory valuation step-up, impairment of goodwill and other long-lived assets, net settlement costs, net restructuring costs, charitable contributions, employer payroll tax on certain stock option exercises, and other miscellaneous expenses related to corporate allocations that were either over or under the original projections at the beginning of the year. We include stock-based compensation and acquisition-related items in the "All Other" category as decisions regarding equity compensation are made at the corporate level and our CODM reviews reportable segment performance exclusive of these charges. Our CODM does not review information regarding total assets, interest income or income taxes on an operating segment basis. The accounting policies for segment reporting are the same as for Broadcom as a whole. 28 The following tables present details of our reportable segments and the "All Other" category:


text:
Quotes & Info
MIND > SEC Filings for MIND > Form 8-K on 3-Jan-2014 | All Recent SEC Filings |
Termination of a Material Definitive Agreement
On November 6, 2012, Mitcham Industries, Inc. (the "Company") entered into an Equipment Purchase Agreement - Unite with Sercel, Inc.(the "Agreement"). The Agreement was amended on June 13, 2013. In the Agreement, the Company agreed to purchase minimum quantities of Sercel's Unite cable-free recording system. In return, the Company was the exclusive authorized third party lessor for the Unite product through September 30, 2014.
In December 2013, the Company notified Sercel that due to market conditions the Company did not anticipate purchasing the minimum quantities specifed in the agreement. On December 27, 2013, Sercel delivered notice to the Company terminating the Agreement due to the failure of the Company to meet the minimum purchase requirements.
The Company does not expect the termination of the Agreement to have a material affect on its business or results of operations.

subset: commoncrawl


text:
Sun, May 6, 12 at 22:28
I ordered bare root strawberry plants, that arrived about 3 weeks ago, w/o instructions. I am quite green when it comes to strawberries, so 2 questions:
1) I was planning to plant them this week, so was reading up, and see I did much wrong, already... should have planted in April or at least should have refrigerated the plants. I didn't. So, at this point, should I give it a whirl, soak them, and plant them anyway, hoping for the best while expecting little? I planned to clip the buds anyway, for a better harvest next year. Or, should I chuck 'em, and try again in the fall? 2) I am planting in plastic bucket containers with good drainage. What medium should I use? Good screened mix topsoil with some sand and peat moss? Something else? I know to dump the soil I used for tomatoes and peppers last year. thanks for all positive input. |
Follow-Up Postings:
- Posted by fruitmaven.WIz5 5 (My Page) on Mon, May 7, 12 at 1:03
May as well try and plant them, you'll probably have some survive. I couldn't resist clearance bare root strawberries from the grocery store, and I'm having a 50% success rate with those (that have been sitting on a shelf for weeks). If you're planting in a container, always use potting mix. Garden soil compacts too much, from the constant watering. If they ate junebearing strawberries, by all means take off this years flowers. Overwinter the containers in the garage, perhaps, since the roots of plants are less hardy than other parts. If the strawberries are day-neutral or everbearing, just remove the flowers for a month or so, you can let them get a few berries at least. Good luck! |
Please Note: Only registered members are able to post messages to this forum. If you are a member, please log in. If you aren't yet a member, join now!
Return to the Fruit & Orchards Forum
Information about Posting
- You must be logged in to post a message. Once you are logged in, a posting window will appear at the bottom of the messages. If you are not a member, please register for an account.
- Please review our Rules of Play before posting.
- Posting is a two-step process. Once you have composed your message, you will be taken to the preview page. You will then have a chance to review your post, make changes and upload photos.
- After posting your message, you may need to refresh the forum page in order to see it.
- Before posting copyrighted material, please read about Copyright and Fair Use.
- We have a strict no-advertising policy!
- If you would like to practice posting or uploading photos, please visit our Test forum.
- If you need assistance, please Contact Us and we will be happy to help.
Learn more about in-text links on this page here


text:
Men's College Basketball | ||||||||||||||||||||||||||||||||||||||||
· Coaching Changes · Conferences · Conference Stats · Gaming Matchup · Injuries (A-M) · Injuries (N-Z) · News · Current Odds · Live Odds · Schedule |
· Top25 Scoreboard · Full Scoreboard · Secondary Scoreboard · Statistics Polls: · AP · USA Today · Division II · Division III |
· Top-25 Analysis · Top 25 Results · Transactions More Basketball · NBA |
The Sports Network DATE & TIME: Thursday, January 16, 9 p.m. (et) FACTS & STATS: Site: Williams Arena (14,625) -- Minneapolis, Minnesota. Television: ESPN2. Home Record: OSU 12-1, UM 10-1. Away Record: OSU 2-1, UM 2-1. Neutral Record: OSU 1-0, UM 1-2. Conference Record: OSU 2-2, UM 2-2. Series Record: Ohio State leads, 82-49. GAME NOTES: The suddenly mortal Ohio State Buckeyes will try to put the brakes on a two-game slide when they challenge the Minnesota Golden Gophers in Big Ten Conference action at Williams Arena on Thursday night. Ohio State had been ranked as high as No. 3 in the country as the team sprinted out to a 15-0 start. That highly-successful run included wins in each of their first two Big Ten bouts, but the Buckeyes, now No. 11 in the country, have suffered defeats in their last two games -- 72-68 on overtime at Michigan State on Jan. 7, and 84-74 to visiting Iowa on Jan. 12. Minnesota has enjoyed a solid start under first-year head coach Richard Pitino, going 13-4 overall and 2-2 in conference. The Golden Gophers are coming off a loss of their own, as they dropped an 87-75 overtime decision at Michigan State last Saturday. UM is hoping for a return to the win column, where its put a tally in 10 of its 11 home games this season. Ohio State owns an 82-49 lead in the all-time series with Minnesota, which includes victories in each of the last six meetings. Lackluster shooting and a lax approach to ball control plagued the Buckeyes for the second straight game, and as a result they lost again. Ohio State shot 44.6 percent from the field against Iowa, which included a 7-of-21 showing from 3-point range, and the team was guilty of 17 turnovers. The Buckeyes had 18 miscues in their loss to Michigan State. LaQuinton Ross tallied 22 points and seven rebounds to pace OSU in both categories against the Hawkeyes, while Amir Williams tacked on 11 points and Lenzelle Smith, Jr. finished with 10. The Buckeyes lost the rebounding battle (40-31), and were outscored at the foul line (21-17). Despite the recent setbacks, Ohio State still has the stats of a team that could very well challenge for the national title. The Buckeyes are averaging 75.1 ppg while permitting a minuscule 57.6 ppg, and their foes are shooting just 38.1 percent from the floor, which includes a 26.9 percent effort from 3- point range. Turnovers have also played an integral role in the team's overall success, as it goads the opposition into nearly 15 miscues per outing. OSO boasts only two double-digit scorers in Ross (13.6 ppg, 5.8 rpg) and Smith, Jr. (12.2 ppg, 4.9 rpg), but five others average between 7.0 and 9.6 ppg in what has truly been a balanced attack this season. Minnesota has been impressive in just about every phase of the game to this point, scoring an average of 75.9 ppg while yielding 67.1 ppg. The team features four double-digit scorers in Andre Hollins (16.3 ppg, 4.1 rpg, 3.1 apg), Austin Hollins (12.1 ppg, 6.7 rpg, 2.5 apg), DeAndre Mathieu (11.4 ppg, 4.4 apg) and Malik Smith (10.1 ppg). Elliott Eliason may only be netting 6.5 ppg, but he makes an impact in other areas as he has blocked 46 shots while pulling down a team-high 8.6 rpg. Despite holding a five-point lead at halftime of their recent clash with Michigan State, the Golden Gophers fell by 12 points in overtime to the nationally-ranked Spartans. Andre Hollins paced Minnesota with 24 points, while Smith came off the bench to add 17. As a team, the Gophers hit just 40.4 percent of their field goal attempts, including a paltry 1-of-9 effort in the extra session, but drained 10 treys in the game while going 19-of-24 at the free-throw line. In contrast, MSU converted 32-of-40 foul shots, 12 of which came in the overtime period to propel it to victory. The Buckeyes need to be on top of their game, or a third straight loss is possible. The Gophers are going to be fired up to prove they belong among the Big Ten's elite. Give them the nod as they give the hometown faithful yet another reason to smile this year. Sports Network Predicted Outcome: Minnesota 68, Ohio State 66 01/16 10:18:54 ET Powered by The Sports Network. |


text:
Wizards vs. Knicks: In-Game Analysis
An in-game analysis of the Washington Wizards vs. New York Knicks Christmas Day game. Read More
Wizards vs. Knicks: Game Preview, Prediction
Previewing and predicting Thursday's game between the Washington Wizards and New York Knicks. Read More
Knicks Have A Healthy Carmelo On Christmas List
The New York Knicks have been atrocious this season, but they have a healthy Carmelo Anthony on the top of their Christmas list. Read More
New York Knicks' Season Already a Lost Cause
As the losses continue to pile up, the New York Knicks have lost grip of this NBA season. If the franchise continues down this path, management and Phil Jackson will have some tough decisions to make. Read More
Chandler Should Feel Sorry For Carmelo Anthony
Tyson Chandler of the Dallas Mavericks is ready to feel sorry for Carmelo Anthony. Read More
Melo To Be Shut Down?
Is Carmelo Anthony's knee injury more serious than he wants to believe? Read More
2015 NBA ASG: Early Predictions For Knicks
The Knicks have had better seasons than this one. Can anyone make the All-Star game? Read More
Carmelo Anthony Is Knicks' Top All-Star Candidate
Carmelo Anthony and the All-Star game go hand in hand. Read More
Knicks vs. Bulls: Game Preview, Prediction
Previewing and predicting Thursday's game between the New York Knicks and Chicago Bulls. Read More
Fire Sale Is Best For Knicks
What is Phil Jackson waiting for? It's time for the New York Knicks to clean house. Read More
Carmelo Should Have Never Left Nuggets
Things are a mess in New York right now, and there doesn't appear to be an end in sight. Would Carmelo Anthony have been better off staying in Denver? Read More
Report Card for the Knicks at the Quarter Mark
The New York Knicks have struggled this season. Here's their report card as we hit the quarter mark. Read More
Cavs, Knicks, and Thunder Discussing Trade
The Cavs, Knicks, and Thunder have discussed the framework of a trade that would involve Dion Waiters, Reggie Jackson, and J.R. Smith. Read More
NBA Rumors: Melo's Back Could Be Season-Long Issue
Carmelo Anthony's back may impact him and the New York Kicks for a while. Should the team and fans be worried? Read More
Carmelo Anthony's Back Could Be Season-Long Issue
Carmelo Anthony is experiencing back spasms which has caused him to miss the past two games. With this be a season-long injury? Read More
New York Knicks Rumors: Smith Trade Inevitable?
As injuries and struggles with a new offensive system continue to plague the New York Knicks, personnel changes could be on the horizon, starting with J.R. Smith. Read More


text:
Isaiah surely had something else in mind when he said, "The people who walk in darkness have seen a great light." And that's fine.
An Old Testament prophet would be concerned with those who had turned their backs on a creed they once believed, commandments they once obeyed, rites they once observed.
For me – a secular humanist struggling to make the world slightly more civilized – this passage sheds light on a different group: People who choose not to see the light – to remain deliberately ignorant, because ignorance suits them better than changing long-held beliefs.
To be sure, we're all guilty of deliberate ignorance at time. In my case, for example, there's a tendency to put off medical tests.
Or use one of those handy online calculators to find out how much I should have saved up in order to live out my golden years in comfort.
Or step onto my bathroom scale.
But – at least when it comes to the great issues confronting my nation and my planet – I try to avoid ignorance. And I find that, as I get older, I have less and less patience with those who choose to walk in darkness with respect to such things.
One of these great issues is global climate change. To my mind, it will be the biggest challenge confronting America, and humanity, in this century.
I didn't always believe that. I didn't want to. My personal and intellectual bent is to think in terms of human progress – the spread of freedom, constitutionalism, education, opportunity, and tolerance to more and more of humanity.
And space travel, of course.
It goes against the grain to think that the great challenge of my lifetime will not involve spreading enlightenment and landing on Mars – but hunkering down to avoid human extinction.
But over time, I've learned too much to deny the threat of climate change. I'm worried. I think we should all be worried.
And I'm getting seriously annoyed with those strident know-nothings who insist that global climate change is a hoax, or part of a natural cycle, or something to do with sunspots.
Now, here's the moment where I could say some pretty harsh things about climate change deniers. The temptation is great.
But I started this column with Isaiah, not Jeremiah – so let's take a different tack.
Because the fact is that climate change deniers are not really the problem. They're a vocal, but ever-so-slowly dwindling, minority in this country.
In a study or public opinion released by Yale and George Mason universities – "Global Warming's Six Americas" – the two groups labeled "Dismissive" and "Doubtful" make up only 10 percent and 15 percent of the American population, respectively.
And that's not nearly enough to stop America from taking serious action – if the rest of us are determined to do so.
On climate change, the key group, as always, are the undecideds. The Yale/GMU study labeled this group "Cautious". These folks – a whopping 29 percent – are the ones who really matter in the climate change debate.
Convince them, and the doubters and deniers are marginalized. Fail to convince them, and nothing much gets done.
So rather than lash the deniers, let me instead appeal to those on my side of the issue – the "Alarmed" and "Concerned" who make up 13 and 26 percent of the population, respectively.
We're the ones who're pretty sure that global climate change is real; that it's serious; that it's the product of human activity; that there's something we can – and must – do about it.
The problem is that most of us don't really have a firm grasp of the science, or the public policy options available for dealing with the threat.
We need to educate ourselves – and then educate our friends and loved ones who are still "Cautious". If we do that, the doubters and deniers can go whistle.
This summer, I took a ten-week, college-level on global climate change, taught by two professors from the University of British Columbia. It was called "Climate Literacy: Navigating Climate Change Conversations," and it included short lectures, reading materials, interactive workshops, and other good things.
All completely free.
Starting September 30, it will be offered again. I hope you'll sign up for it.
To be sure, it's a serious undertaking. It's not hard, but it will require a commitment of three or four hours a week for ten weeks.
If you stick to it, you'll learn a lot. I urge you sign up – if possible, with a few friends.
From my experience, the one weakness of MOOCs is that they lack direct, human interaction. If you convince a few friends to take the course – and meet once a week to discuss it over coffee – that problem would be alleviated.
You'd probably learn more, too.
Climate change is important.
It's time to stop walking in darkness, don't you think?


text:
Has Google killed guest blogging?
The keener eyed of you might raise an eyebrow that a guest blogger is tackling this topic, but over the past week guest blogging has come once again under scrutiny.
The industry chatter about the risks of guest blogging has been getting louder for more than a year. The first the warning shot was fired by Google's head of web spam Matt Cutts with his decay and fall of guest blogging post. Three months later and after a host of website penalties, it had become clear that guest posting was indeed a major risk if undertaken for the objective of SEO. Read More


text:
Your cart is empty!
is a traditional homeopathic formula in a non-greasy base. This ointment works quickly to relieve the symptoms of cramps and pains in the legs and calves while warming the affected area. Whether it is in the middle of the night or in the light of day, Hyland's Leg Cramps Ointment is a real and natural solution to this troublesome leg problem.
Active Ingredients
Aconitum Napellus (Monkshood) 3X HPUS (Shooting Pain in Legs), Arnica Montana (Montana Flower) 3X HPUS (Leg Pain that Starts Low & Moves Up Leg), Ledum Palustre 3X HPUS (Rheumatic Pains in Legs), Mag. Phos. 10X HPUS (Cramps in Calves), Rhus Toxicodendron 6X HPUS (Leg Pain Relieved by Warmth), Viscum Album (Mistletoe) 3X, HPUS (Shooting Pain in Legs).
Inactive Ingredients
Olive Oil NF, Stearyl Alcohol N.F., Wintergreen Oil (Natural), Kokam Butter, Glyceryl Monostearate N.F., Soy Lecithin N.F., Methylparaben, Propylparaben NF, Butylparaben.
Apply liberally to affected area. Hyland's Leg Cramps Ointment will warm the area while easing the symptoms.
For external use only. Do not use if tube seal is broken or missing. If symptoms persist for more than 7 days or worsen, contact a licensed health care provide. Keep this and all medications out of the reach of children.
Jarrow Formulas reduce form Co-Q10 ubiquinol QH-absorb 200 mg softgels - 30 ea
Our Price:$31.25
Boiron Calendula First Aid Homeopathic Ointment For Cuts, Chapping, Burns And Scrapes - 1 oz
Our Price:$4.68
Hylands homeopathic Belladonna 30X tablets - 250 ea
Our Price:$5.51
Hylands homeopathic medicine aconitum napellus 30X, colds and fevers - 250 tablets
Bach original flower essences for naturally occurring nervous tension, Scleranthus, 20 ml
Our Price:$11.60
Bioforce A.Vogel stress management dietary supplement drops, 1.7 oz
Our Price:$12.52
Product descriptions and images presented on the site are for representational use only and do not constitute or substitute for medical information from your health care or medical professional. Information on this site is provided for informational purposes only. You should read carefully all on correct product packaging and follow the instructions. If you have or suspect that you have a medical problem, promptly contact your health care provider. Information and statements regarding dietary supplements on this site have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease and may be for commercial. Image shown for reference only. Actual item you recieve may differ from shown.